Jian Wang

Jian Wang

Auto-generated profile, based on publicly available information

Jian Wang

Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cell
Verified
Journal Article
Open access
JWJian Wang
Jian Wang
IJIvan Jelcic
Ivan Jelcic
LMLena Mühlenbruch
Lena Mühlenbruch
VHVeronika Haunerdinger
Veronika Haunerdinger
NTNora C. Toussaint
Nora C. Toussaint
RMRoland Martin
Roland Martin
The HLA-DR15 haplotype is the strongest genetic risk factor for multiple sclerosis (MS), but our understanding of how it contributes to MS is limited. Because autoreactive CD4+ T cells and B cells as antigen-presenting cells are involved in MS pathogenesis, we characterized the immunopeptidomes of the two HLA-DR15 allomorphs DR2a and DR2b of human primary B cells and monocytes, thymus, and MS brain tissue. Self-peptides from HLA-DR molecules, particularly from DR2a and DR2b themselves, are abundant on B cells and thymic antigen-presenting cells. Furthermore, we identified autoreactive CD4+ T cell clones that can cross-react with HLA-DR-derived self-peptides (HLA-DR-SPs), peptides from MS-associated foreign agents (Epstein-Barr virus and Akkermansia muciniphila), and autoantigens presented by DR2a and DR2b. Thus, both HLA-DR15 allomorphs jointly shape an autoreactive T cell repertoire by serving as antigen-presenting structures and epitope sources and by presenting the same foreign peptides and autoantigens to autoreactive CD4+ T cells in MS.

1 February 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
TLTingting Li
Tingting Li
JWJian Wang
Jian Wang
YWYanshi Wang
Yanshi Wang
YCYongyan Chen
Yongyan Chen
HWHaiming Wei
Haiming Wei
ZTZhi-gang Tian
Zhi-gang Tian
Although NK cells are classified as innate immune cells, recent studies have demonstrated the transformation of NK cells into long-lived memory cells that contribute to secondary immune responses in certain mouse models. However, whether NK cells mount an Ag-specific memory response to acute influenza virus infection has not yet been examined. Here, we show that, consistent with previous studies, lung NK cells play an important role in controlling viral proliferation after primary influenza virus infection. However, although lung NK cells display a memory phenotype at the late stage of infection, these cells do not protect mice against secondary influenza virus infection. Interestingly, liver NK cells from influenza virus–infected mice possess a memory phenotype and protect mice against secondary influenza virus infection. Memory-like liver NK cells display a CD49a+DX5− phenotype, and the adoptive transfer of purified liver CD49a+DX5− NK cells into naive mice followed by viral infection results in protective immunity and decreased viral titer. Moreover, we demonstrate that primary inactivated influenza virus induces memory NK cells residing in the liver of Rag1−/− mice. Collectively, these data suggest that liver CD49a+DX5− NK cells remember encountered Ag from influenza virus after primary infection and are more protective upon subsequent infection.

27 November 2019 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
CHChao Huang
Chao Huang
FLFengqi Li
Fengqi Li
JWJian Wang
Jian Wang
ZTZhi-gang Tian
Zhi-gang Tian

13 October 2022 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
JWJian Wang
Jian Wang
TWTobias Weiss
Tobias Weiss
MNMarian C. Neidert
Marian C. Neidert
NTNora C. Toussaint
Nora C. Toussaint
RNReza Naghavian
Reza Naghavian
RMRoland Martin
Roland Martin
Purpose: The low mutational load of some cancers is considered one reason for the difficulty to develop effective tumor vaccines. To overcome this problem, we developed a strategy to design neopeptides through single amino acid mutations to enhance their immunogenicity. Experimental Design: Exome and RNA sequencing as well as in silico HLA-binding predictions to autologous HLA molecules were used to identify candidate neopeptides. Subsequently, in silico HLA-anchor placements were used to deduce putative T-cell receptor (TCR) contacts of peptides. Single amino acids of TCR contacting residues were then mutated by amino acid replacements. Overall, 175 peptides were synthesized and sets of 25 each containing both peptides designed to bind to HLA class I and II molecules applied in the vaccination. Upon development of a tumor recurrence, the tumor-infiltrating lymphocytes (TIL) were characterized in detail both at the bulk and clonal level. Results: The immune response of peripheral blood T cells to vaccine peptides, including natural peptides and designed neopeptides, gradually increased with repetitive vaccination, but remained low. In contrast, at the time of tumor recurrence, CD8+ TILs and CD4+ TILs responded to 45% and 100%, respectively, of the vaccine peptides. Furthermore, TIL-derived CD4+ T-cell clones showed strong responses and tumor cell lysis not only against the designed neopeptide but also against the unmutated natural peptides of the tumor. Conclusions: Turning tumor self-peptides into foreign antigens by introduction of designed mutations is a promising strategy to induce strong intratumoral CD4+ T-cell responses in a cold tumor like glioblastoma.

18 April 2022 in Indian Journal of Surgery
Verified
Journal Article
Open access
PDF file
TLTianshi Lyu
Tianshi Lyu
SCShoujin Cao
Shoujin Cao
JWJian Wang
Jian Wang
SLSong Li
Song Li
XTXiaoqiang Tong
Xiaoqiang Tong
YZYinghua Zou
Yinghua Zou
Catheter rupture or displacement is a serious and rare complication of central venous catheterization, with an incidence of approximately 1%. Once the intravascular foreign body is found, it should be removed as soon as possible. This study investigated the safety and efficacy of endovascular techniques for the removal of intravascular foreign bodies. This was a retrospective analysis of 23 patients with intravascular foreign bodies admitted to our hospital from January 2009 to June 2019 summarizing the types and locations of foreign bodies and the removal techniques. Overall Twenty-three cases of intravascular foreign bodies were successfully treated with endovascular techniques, for a technical success rate of 100%. The types of foreign bodies included 14 infusion port catheters (60.9%), 6 peripherally inserted central catheters (26.1%), 2 temporary deep vein catheters (8.7%), and 1 intravenous stent (4.3%). The most common orientation of foreign body displacement was one end of the foreign body in the inferior vena cava and the other end in the right atrium (14/23, 60.9%). In terms of technique, all patients underwent removal procedures with only one venous access point. The operative time ranged from 6 to 153 min, with an average of 28.7 min. This study preliminarily demonstrates the safety and efficacy of percutaneous interventional intravascular foreign body removal. Endovascular techniques are minimally invasive and reliable and can be used to safely and effectively remove intravascular foreign bodies.

25 November 2025
Verified
Other
Open access
JWJian Wang
Jian Wang
TWTobias Weiss
Tobias Weiss
MNMarian C. Neidert
Marian C. Neidert
NTNora C. Toussaint
Nora C. Toussaint
RNReza Naghavian
Reza Naghavian
RMRoland Martin
Roland Martin
Predicted TSA/TAA-derived N-peptides and D-neopeptides